PF-06465469 is a covalent inhibitor of ITK with an IC50 of 2 nM[1].
References:
[1]. Mamand S, et al. Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma. Sci Rep. 2018 Sep 21;8(1):14216.
















